- $170.84m
- $340.72m
- $258.90m
Annual balance sheet for Zepp Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 20-F | 20-F | 6-K | 20-F | 6-K |
| Standards: | USG | USG | USG | USG | — |
| Status: | fx Final | fx Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 235 | 134 | 139 | 92.1 | 57 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 171 | 126 | 82 | 79.1 | 73.6 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 619 | 429 | 317 | 252 | 294 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 38.1 | 24.1 | 15.7 | 10.4 | 7.62 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 958 | 764 | 636 | 529 | 565 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 339 | 242 | 155 | 195 | 287 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 498 | 376 | 285 | 277 | 350 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 460 | 387 | 351 | 252 | 215 |
| Total Liabilities & Shareholders' Equity | 958 | 764 | 636 | 529 | 565 |
| Total Common Shares Outstanding |